Literature DB >> 31554525

Recommendations from the Association for European Paediatric and Congenital Cardiology for training in pulmonary hypertension.

Hannes Sallmon1, Shahin Moledina2, Dimpna C Albert3, Maurice Beghetti4, Rolf M F Berger5, Damien Bonnet6, Mila Bukova7, Martin Koestenberger8, Katharina Meinel8, Zdenka Reinhardt9, Robert M R Tulloh10, Daniel de Wolf11, Georg Hansmann7.   

Abstract

Pulmonary hypertension is a complex and progressive condition that is either idiopathic or heritable, or associated with one or multiple health conditions, with or without congenital or acquired cardiovascular disease. Recent developments have tremendously increased the armamentarium of diagnostic and therapeutic approaches in children and young adults with pulmonary hypertension that is still associated with a high morbidity and mortality. These modalities include non-invasive imaging, pharmacotherapy, interventional and surgical procedures, and supportive measures. The optimal, tailored diagnostic and therapeutic strategies for pulmonary hypertension in the young are rapidly evolving but still face enormous challenges: Healthcare providers need to take the patient's age, development, disease state, and family concerns into account when initiating advanced diagnostics and treatment. Therefore, there is a need for guidance on core and advanced medical training in paediatric pulmonary hypertension. The Association for European Paediatric and Congenital Cardiology working group "pulmonary hypertension, heart failure and transplantation" has produced this document as an expert consensus statement; however, all recommendations must be considered and applied in the context of the local and national infrastructure and legal regulations.

Entities:  

Keywords:  Association for European Paediatric and Congenital Cardiology; Pulmonary hypertension; children; heart disease; young adults

Mesh:

Year:  2019        PMID: 31554525     DOI: 10.1017/S104795111900235X

Source DB:  PubMed          Journal:  Cardiol Young        ISSN: 1047-9511            Impact factor:   1.093


  2 in total

1.  Paediatric/congenital cardiology physician scientists-An endangered species.

Authors:  Georg Hansmann; Vassilios Bezzerides
Journal:  Eur J Clin Invest       Date:  2020-09-05       Impact factor: 4.686

Review 2.  Pulmonary hypertension in bronchopulmonary dysplasia.

Authors:  Georg Hansmann; Hannes Sallmon; Charles C Roehr; Stella Kourembanas; Eric D Austin; Martin Koestenberger
Journal:  Pediatr Res       Date:  2020-06-10       Impact factor: 3.756

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.